| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months (pa) | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | Insync employs four simple screens to narrow the universe of over 40,000 listed companies globally to a focus group of high-quality companies that it believes have the potential to consistently grow their profits and dividends. These screens are: size of the company, balance sheet performance, valuation and dividend quality. Companies that pass this due diligence process are then valued using dividend discount models, free cash flow yield and proprietary implied growth and expected return models. The end result is a high conviction portfolio typically of 15-30 stocks. The principal investments will be in shares of companies listed on international stock exchanges (including the US, Europe and Asia). The Fund may also hold cash, derivatives (for example futures, options and swaps), currency contracts, American Depository Receipts and Global Depository Receipts. The Fund may also invest in various types of international pooled investment vehicles. |
| Manager Comments | September and October saw a cyclical rotation towards value-based stocks which affected the short-term performance of the Fund. However, Insync noted the one area of consistency in this cycle has been the performance of quality growth companies. Their view is that current market conditions continue to reflect the trend in place since the GFC of low growth and low inflation. Positive contributors in November included Walt Disney, Adobe, Accenture and Amadeus. Detractors included Stryker, Zoetis, IDEXX Laboratories and Booking Holdings. Insync continues to have no currency hedging in place as they consider the main risks to the Australian dollar to be on the downside. |
| More Information |
